Nautilus Biotechnology Stock Price History
NAUT Stock | USD 2.30 0.06 2.68% |
Below is the normalized historical share price chart for Nautilus Biotechnology extending back to August 07, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Nautilus Biotechnology stands at 2.30, as last reported on the 28th of November, with the highest price reaching 2.38 and the lowest price hitting 2.25 during the day.
If you're considering investing in Nautilus Stock, it is important to understand the factors that can impact its price. Nautilus Biotechnology has Sharpe Ratio of -0.029, which conveys that the firm had a -0.029% return per unit of risk over the last 3 months. Nautilus Biotechnology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nautilus Biotechnology's Risk Adjusted Performance of (0.02), standard deviation of 3.89, and Mean Deviation of 3.05 to check out the risk estimate we provide.
Total Stockholder Equity is likely to drop to about 171.8 M in 2024. Common Stock Total Equity is likely to drop to about 13.1 K in 2024. At this time, Nautilus Biotechnology's Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 2.12 in 2024, whereas Price To Operating Cash Flows Ratio is likely to drop (7.58) in 2024. Nautilus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of June 2021 | 200 Day MA 2.6268 | 50 Day MA 2.6801 | Beta 1.036 |
Nautilus |
Sharpe Ratio = -0.029
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | NAUT |
Estimated Market Risk
3.94 actual daily | 35 65% of assets are more volatile |
Expected Return
-0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Nautilus Biotechnology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nautilus Biotechnology by adding Nautilus Biotechnology to a well-diversified portfolio.
Price Book 1.2925 | Book Value 1.779 | Enterprise Value 179.8 M | Enterprise Value Ebitda (2.00) | Shares Float 41.9 M |
Nautilus Biotechnology Stock Price History Chart
There are several ways to analyze Nautilus Stock price data. The simplest method is using a basic Nautilus candlestick price chart, which shows Nautilus Biotechnology price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 20, 2024 | 3.08 |
Lowest Price | November 19, 2024 | 2.24 |
Nautilus Biotechnology November 28, 2024 Stock Price Synopsis
Various analyses of Nautilus Biotechnology's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Nautilus Stock. It can be used to describe the percentage change in the price of Nautilus Biotechnology from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Nautilus Stock.Nautilus Biotechnology Price Action Indicator | 0.01 | |
Nautilus Biotechnology Price Rate Of Daily Change | 1.03 | |
Nautilus Biotechnology Price Daily Balance Of Power | 0.46 |
Nautilus Biotechnology November 28, 2024 Stock Price Analysis
Nautilus Stock Price History Data
The price series of Nautilus Biotechnology for the period between Fri, Aug 30, 2024 and Thu, Nov 28, 2024 has a statistical range of 0.84 with a coefficient of variation of 7.56. The daily prices for the period are spread out with arithmetic mean of 2.68. The median price for the last 90 days is 2.7.Open | High | Low | Close | Volume | ||
11/28/2024 | 2.25 | 2.38 | 2.25 | 2.30 | ||
11/27/2024 | 2.25 | 2.38 | 2.25 | 2.30 | 72,249 | |
11/26/2024 | 2.47 | 2.47 | 2.21 | 2.24 | 220,233 | |
11/25/2024 | 2.42 | 2.51 | 2.40 | 2.44 | 59,957 | |
11/22/2024 | 2.40 | 2.50 | 2.38 | 2.40 | 108,352 | |
11/21/2024 | 2.36 | 2.43 | 2.28 | 2.38 | 101,746 | |
11/20/2024 | 2.22 | 2.35 | 2.21 | 2.34 | 68,423 | |
11/19/2024 | 2.30 | 2.34 | 2.23 | 2.24 | 155,580 | |
11/18/2024 | 2.31 | 2.37 | 2.27 | 2.32 | 81,274 | |
11/15/2024 | 2.49 | 2.49 | 2.30 | 2.30 | 113,916 | |
11/14/2024 | 2.48 | 2.51 | 2.43 | 2.46 | 81,680 | |
11/13/2024 | 2.52 | 2.55 | 2.44 | 2.47 | 77,844 | |
11/12/2024 | 2.43 | 2.58 | 2.40 | 2.49 | 159,654 | |
11/11/2024 | 2.57 | 2.67 | 2.35 | 2.42 | 546,896 | |
11/08/2024 | 2.67 | 2.68 | 2.44 | 2.49 | 159,299 | |
11/07/2024 | 2.84 | 2.92 | 2.66 | 2.66 | 145,693 | |
11/06/2024 | 2.81 | 2.90 | 2.74 | 2.89 | 241,363 | |
11/05/2024 | 2.56 | 2.69 | 2.55 | 2.64 | 58,470 | |
11/04/2024 | 2.59 | 2.66 | 2.46 | 2.57 | 55,381 | |
11/01/2024 | 2.65 | 2.72 | 2.60 | 2.61 | 39,043 | |
10/31/2024 | 2.65 | 2.71 | 2.60 | 2.60 | 48,818 | |
10/30/2024 | 2.81 | 2.82 | 2.65 | 2.65 | 43,424 | |
10/29/2024 | 2.68 | 2.89 | 2.63 | 2.77 | 107,203 | |
10/28/2024 | 2.73 | 2.82 | 2.69 | 2.81 | 79,329 | |
10/25/2024 | 2.75 | 2.77 | 2.69 | 2.69 | 48,116 | |
10/24/2024 | 2.78 | 2.80 | 2.71 | 2.72 | 35,239 | |
10/23/2024 | 2.76 | 2.78 | 2.68 | 2.75 | 36,050 | |
10/22/2024 | 2.80 | 2.82 | 2.74 | 2.78 | 253,901 | |
10/21/2024 | 2.92 | 2.95 | 2.76 | 2.77 | 49,717 | |
10/18/2024 | 2.87 | 2.97 | 2.81 | 2.95 | 107,010 | |
10/17/2024 | 2.95 | 2.99 | 2.86 | 2.87 | 48,901 | |
10/16/2024 | 2.89 | 3.03 | 2.84 | 2.96 | 87,813 | |
10/15/2024 | 2.82 | 2.91 | 2.78 | 2.84 | 51,552 | |
10/14/2024 | 2.80 | 2.86 | 2.77 | 2.82 | 34,112 | |
10/11/2024 | 2.72 | 2.88 | 2.69 | 2.86 | 72,754 | |
10/10/2024 | 2.74 | 2.78 | 2.69 | 2.71 | 39,080 | |
10/09/2024 | 2.69 | 2.83 | 2.68 | 2.79 | 40,525 | |
10/08/2024 | 2.67 | 2.75 | 2.67 | 2.69 | 26,856 | |
10/07/2024 | 2.69 | 2.71 | 2.62 | 2.66 | 35,323 | |
10/04/2024 | 2.69 | 2.73 | 2.64 | 2.71 | 37,855 | |
10/03/2024 | 2.70 | 2.73 | 2.60 | 2.63 | 47,251 | |
10/02/2024 | 2.68 | 2.77 | 2.68 | 2.73 | 53,111 | |
10/01/2024 | 2.86 | 2.86 | 2.70 | 2.70 | 50,980 | |
09/30/2024 | 2.88 | 2.94 | 2.81 | 2.85 | 42,505 | |
09/27/2024 | 2.89 | 2.93 | 2.86 | 2.91 | 37,642 | |
09/26/2024 | 2.83 | 2.89 | 2.79 | 2.85 | 69,578 | |
09/25/2024 | 3.02 | 3.02 | 2.82 | 2.82 | 84,043 | |
09/24/2024 | 2.80 | 3.05 | 2.73 | 3.02 | 107,978 | |
09/23/2024 | 3.09 | 3.09 | 2.77 | 2.79 | 149,555 | |
09/20/2024 | 2.90 | 3.09 | 2.87 | 3.08 | 357,456 | |
09/19/2024 | 2.88 | 3.02 | 2.88 | 3.00 | 94,506 | |
09/18/2024 | 2.87 | 3.00 | 2.85 | 2.87 | 94,625 | |
09/17/2024 | 2.95 | 3.01 | 2.73 | 2.91 | 165,592 | |
09/16/2024 | 2.90 | 2.99 | 2.85 | 2.96 | 89,500 | |
09/13/2024 | 2.78 | 2.90 | 2.76 | 2.90 | 71,388 | |
09/12/2024 | 2.76 | 2.78 | 2.72 | 2.73 | 39,366 | |
09/11/2024 | 2.79 | 2.83 | 2.63 | 2.75 | 46,912 | |
09/10/2024 | 2.66 | 2.85 | 2.63 | 2.82 | 96,966 | |
09/09/2024 | 2.54 | 2.68 | 2.54 | 2.66 | 52,154 | |
09/06/2024 | 2.56 | 2.61 | 2.53 | 2.55 | 39,159 | |
09/05/2024 | 2.49 | 2.58 | 2.47 | 2.57 | 58,669 |
About Nautilus Biotechnology Stock history
Nautilus Biotechnology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nautilus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nautilus Biotechnology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nautilus Biotechnology stock prices may prove useful in developing a viable investing in Nautilus Biotechnology
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 124.9 M | 69.4 M | |
Net Loss | -52.1 M | -54.7 M |
Nautilus Biotechnology Quarterly Net Working Capital |
|
Nautilus Biotechnology Stock Technical Analysis
Nautilus Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Latest Portfolios Now
Latest PortfoliosQuick portfolio dashboard that showcases your latest portfolios |
All Next | Launch Module |
Nautilus Biotechnology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Nautilus Biotechnology's price direction in advance. Along with the technical and fundamental analysis of Nautilus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Nautilus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.43) | |||
Total Risk Alpha | (0.73) | |||
Treynor Ratio | (0.06) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Nautilus Stock Analysis
When running Nautilus Biotechnology's price analysis, check to measure Nautilus Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nautilus Biotechnology is operating at the current time. Most of Nautilus Biotechnology's value examination focuses on studying past and present price action to predict the probability of Nautilus Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nautilus Biotechnology's price. Additionally, you may evaluate how the addition of Nautilus Biotechnology to your portfolios can decrease your overall portfolio volatility.